Clinical Trial Update: Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study of levetiracetam in subjects 4 years and older with generalized epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Generalized Epilepsy | Phase 3 | Status: COMPLETED